Loading...

BHC - Bausch Health Companies Inc.

Oversold Signal for 06-15-2022
Oversold Stock Signal: BHC


Loading Chart BHC

Stock Signal Information


Signal

Oversold Stock Signal: BHC
Report Date: 06-15-2022
Symbol: BHC - Bausch Health Companies Inc.
Sector:
Industry:
Oversold Stock Signal: BHC

  BHC Technical Analysis

Company Contact

Bausch Health Companies Inc. (BHC)
2150 Saint-Elzear Blvd W
Laval, QUEBEC H7L 4A8
Phone: 15147446792
Website: https://www.bauschhealth.com
CEO: Mr. Joseph Papa

BHC, Bausch Health Companies Inc.

BHC Bausch Health Companies Inc. Logo Image

NYSE, New York Stock Exchange


Company Profile

Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.